Advances in diagnostic and treatment options in patients with fibromyalgia syndrome

Ali Gur1, Pelin Oktayoglu21Department of Physical Medicine and Rehabilitation, Medical Faculty, Gaziantep University, Gaziantep, Turkey; 2Department of Physical Medicine and Rehabilitation, Batman State Hospital, Batman, TurkeyAbstract: Fibromyalgia (FM) is characterized as a chronic, painful, nonin...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ali Gur, Pelin Oktayoglu
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/76e541bfb36b4aea95b4bcaf9ebe4e97
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:76e541bfb36b4aea95b4bcaf9ebe4e97
record_format	dspace
spelling	oai:doaj.org-article:76e541bfb36b4aea95b4bcaf9ebe4e972021-12-02T04:28:56ZAdvances in diagnostic and treatment options in patients with fibromyalgia syndrome1179-156Xhttps://doaj.org/article/76e541bfb36b4aea95b4bcaf9ebe4e972009-12-01T00:00:00Zhttp://www.dovepress.com/advances-in-diagnostic-and-treatment-options-in-patients-with-fibromya-a3823https://doaj.org/toc/1179-156XAli Gur1, Pelin Oktayoglu21Department of Physical Medicine and Rehabilitation, Medical Faculty, Gaziantep University, Gaziantep, Turkey; 2Department of Physical Medicine and Rehabilitation, Batman State Hospital, Batman, TurkeyAbstract: Fibromyalgia (FM) is characterized as a chronic, painful, noninflammatory syndrome affecting the musculoskeletal system. In addition to pain, common co-morbid symptoms associated with FM include sleep disturbances, fatigue, morning stiffness, affective disorders, chronic daily headache, dyscognition, irritable bowel syndrome, and irritable bladder. Fibromyalgia is usually classified by application of the American College of Rheumatology (ACR) criteria. Although these criteria are accepted among investigators who agree with the concept of fibromyalgia, they do so with some reservations. Tender points and widespread pain alone does not describe the esence of fibromyalgia. New diagnostic tools including either clinical or radiological components are studied to diminish these problems. Although various pharmacological solutions have been studied for treating fibromyalgia, no single drug or groups of drugs have proved to be useful in treating fibromyalgia patients. Recently, three drugs, pregabalin, duloxetine and milnacipran, were approved for the treatment of FM by the US Food and Drug Administration (FDA). Novel therapeutic approaches to the management of FM include cannabinoids, sodium channel blockade and new generation antiepileptics. This review evaluates both new diagnostic tools, including clinical or radiological regimes, and tries to highlight the efficacy of medicinal and nonmedicinal treatments with new therapeutic approaches in the management of FM with a wide perspective.Keywords: diagnosis, fibromyalgia, rehabilitation, treatment Ali GurPelin OktayogluDove Medical PressarticleDiseases of the musculoskeletal systemRC925-935ENOpen Access Rheumatology: Research and Reviews, Vol 2009, Iss default, Pp 193-209 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the musculoskeletal system RC925-935
spellingShingle	Diseases of the musculoskeletal system RC925-935 Ali Gur Pelin Oktayoglu Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
description	Ali Gur1, Pelin Oktayoglu21Department of Physical Medicine and Rehabilitation, Medical Faculty, Gaziantep University, Gaziantep, Turkey; 2Department of Physical Medicine and Rehabilitation, Batman State Hospital, Batman, TurkeyAbstract: Fibromyalgia (FM) is characterized as a chronic, painful, noninflammatory syndrome affecting the musculoskeletal system. In addition to pain, common co-morbid symptoms associated with FM include sleep disturbances, fatigue, morning stiffness, affective disorders, chronic daily headache, dyscognition, irritable bowel syndrome, and irritable bladder. Fibromyalgia is usually classified by application of the American College of Rheumatology (ACR) criteria. Although these criteria are accepted among investigators who agree with the concept of fibromyalgia, they do so with some reservations. Tender points and widespread pain alone does not describe the esence of fibromyalgia. New diagnostic tools including either clinical or radiological components are studied to diminish these problems. Although various pharmacological solutions have been studied for treating fibromyalgia, no single drug or groups of drugs have proved to be useful in treating fibromyalgia patients. Recently, three drugs, pregabalin, duloxetine and milnacipran, were approved for the treatment of FM by the US Food and Drug Administration (FDA). Novel therapeutic approaches to the management of FM include cannabinoids, sodium channel blockade and new generation antiepileptics. This review evaluates both new diagnostic tools, including clinical or radiological regimes, and tries to highlight the efficacy of medicinal and nonmedicinal treatments with new therapeutic approaches in the management of FM with a wide perspective.Keywords: diagnosis, fibromyalgia, rehabilitation, treatment
format	article
author	Ali Gur Pelin Oktayoglu
author_facet	Ali Gur Pelin Oktayoglu
author_sort	Ali Gur
title	Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
title_short	Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
title_full	Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
title_fullStr	Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
title_full_unstemmed	Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
title_sort	advances in diagnostic and treatment options in patients with fibromyalgia syndrome
publisher	Dove Medical Press
publishDate	2009
url	https://doaj.org/article/76e541bfb36b4aea95b4bcaf9ebe4e97
work_keys_str_mv	AT aligur advancesindiagnosticandtreatmentoptionsinpatientswithfibromyalgiasyndrome AT pelinoktayoglu advancesindiagnosticandtreatmentoptionsinpatientswithfibromyalgiasyndrome
_version_	1718401193339781120

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome

Ejemplares similares